Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update Introduction of new immune therapies that may have a delayed ...
Introduction of new immune therapies that may have a delayed beneficial effect necessitates re-evaluation of traditional clinical trial designs in oncology. A key design feature of randomized trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback